Exiqon's Q3 Revenues Increase 30 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exiqon reported today that its third-quarter revenues jumped 30 percent year over year.

The Danish miRNA research products and diagnostics firm brought in total revenues of DKK 27.1 million ($5 million) for the quarter ended Sept. 30, compared to DKK 20.9 million for the third quarter of 2010. It said that its research product sales grew 33 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.